Emergent BioSolutions Repurchases $75 Million of Debt at Discount

Emergent BioSolutions Inc. (NYSE: EBS) has repurchased $75 million in principal amount of its senior unsecured notes due in 2028,... Read More

The post Emergent BioSolutions Repurchases $75 Million of Debt at Discount appeared first on citybiz.